# FHTX (Foghorn Therapeutics Inc.) - SEC EDGAR Financial Statements

> Foghorn Therapeutics Inc. reported $112.1M in revenue and net income of $9.42M for the trailing twelve months ended September 30, 2026 (up 924.7% year over year), with a 2.1% operating margin.

- Canonical: https://convexityos.com/fundamentals/FHTX
- Markdown: https://convexityos.com/fundamentals/FHTX.md
- SEC CIK: 0001822462
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:48 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001822462&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $112.1M | +924.7% YoY |
| Operating Income | TTM | $2.38M | 2.1% margin |
| Net Income | TTM | $9.42M | 8.4% net margin |
| Diluted EPS | TTM | $0.13 | Split-adjusted |
| Free Cash Flow | TTM | -$83.68M | -74.6% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $80.30M | Total debt: $43.87M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $30.91M | $22.60M | $34.16M | $19.23M | $1.32M | $430K | -- |
| Research & Development | $85.47M | $94.53M | $109.7M | $105.6M | $80.33M | $57.72M | $44.36M |
| Total Operating Expenses | $117.3M | $125.3M | $142.1M | $136.4M | $102.1M | $68.96M | $51.08M |
| **Operating Income** | -$86.39M | -$102.7M | -$107.9M | -$117.1M | -$100.7M | -$68.53M | -$51.08M |
| **EBITDA** | -$83.06M | -$99.56M | -$104.5M | -$113.8M | -$97.51M | -$67.20M | -$50.39M |
| Interest Income | $8.74M | $11.90M | $10.88M | $5.67M | $59K | -- | -- |
| Interest Expense | -- | -- | -- | -- | $1.91M | $979K | $540K |
| Income Before Tax | -- | -$86.62M | -$94.20M | -$108.9M | -- | -- | -- |
| Income Tax Expense | $0 | $0 | $4.23M | $0 | -- | $0 | $0 |
| **Net Income** | -$74.28M | -$86.62M | -$98.43M | -$108.9M | -$101.3M | -$68.80M | -$51.13M |
| Basic EPS | -$1.18 | -$1.58 | -$2.34 | -$2.62 | -$2.73 | -$6.23 | -$12.20 |
| **Diluted EPS** | -$1.18 | -$1.58 | -$2.34 | -$2.62 | -$2.73 | -$6.23 | -$12.20 |
| Basic Shares Outstanding | 63.0M | 54.9M | 42.0M | 41.6M | 37.2M | 11.0M | 4.2M |
| Diluted Shares Outstanding | 63.0M | 54.9M | 42.0M | 41.6M | 37.2M | 11.0M | 4.2M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $83.54M | $16.07M | $3.27M | $9.25M | $8.15M | $7.56M | $5.95M | $2.86M |
| Research & Development | $18.84M | $18.52M | $18.26M | $22.05M | $20.00M | $21.79M | $21.63M | $20.51M |
| Total Operating Expenses | $26.90M | $24.88M | $24.84M | $33.12M | $26.65M | $28.65M | $28.86M | $26.86M |
| **Operating Income** | $56.64M | -$8.80M | -$21.57M | -$23.88M | -$18.50M | -$21.10M | -$22.91M | -$24.00M |
| **EBITDA** | $56.84M | -$8.61M | -$21.34M | -$23.08M | -$17.60M | -$20.20M | -$22.09M | -$23.24M |
| Interest Income | $1.53M | $1.61M | $1.74M | $1.71M | $2.03M | $2.31M | $2.69M | $3.10M |
| Income Before Tax | -- | -- | -- | -- | -- | -- | -- | -$19.50M |
| Income Tax Expense | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Net Income** | $58.15M | -$7.19M | -$19.88M | -$21.66M | -$15.85M | -$17.94M | -$18.83M | -$19.50M |
| Basic EPS | $0.81 | -$0.10 | -$0.29 | -- | -$0.25 | -$0.28 | -$0.30 | -- |
| **Diluted EPS** | $0.80 | -$0.10 | -$0.29 | -- | -$0.25 | -$0.28 | -$0.30 | -- |
| Basic Shares Outstanding | 71.5M | 70.6M | 69.5M | -- | 63.0M | 63.0M | 62.8M | -- |
| Diluted Shares Outstanding | 72.6M | 70.6M | 69.5M | -- | 63.0M | 63.0M | 62.8M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $80.88M | $55.45M | $80.34M | $52.21M | $101.1M | $92.80M | $14.98M |
| **Cash & Short-Term Investments** | $80.88M | $55.45M | $80.34M | $52.21M | $101.1M | $92.80M | $14.98M |
| **Total Current Assets** | $163.2M | $249.6M | $240.2M | $351.4M | $459.6M | $190.7M | $16.89M |
| Property, Plant & Equipment, Net | $1.92M | $9.96M | $12.96M | $15.31M | $17.56M | $19.53M | $2.68M |
| Other Non-Current Assets | $4.0K | $68K | $1.11M | $2.38M | $2.40M | $842K | $11K |
| **Total Non-Current Assets** | $34.87M | $34.38M | $45.73M | $53.48M | $60.21M | $64.91M | $5.46M |
| **Total Assets** | $198.1M | $284.0M | $285.9M | $404.9M | $519.8M | $255.6M | $22.34M |
| Accounts Payable | $4.27M | $3.79M | $6.26M | $5.41M | $3.82M | $3.68M | $3.44M |
| Short-Term Debt | -- | -- | -- | -- | -- | $0 | $4.15M |
| Deferred Revenue (Current) | $43.19M | $45.61M | $34.55M | $32.82M | $28.32M | $2.02M | -- |
| **Total Current Liabilities** | $59.74M | $66.99M | $58.44M | $55.20M | $48.69M | $18.85M | $12.65M |
| Long-Term Debt | -- | -- | -- | -- | $0 | $19.65M | $10.96M |
| Deferred Revenue (Non-Current) | $206.0M | $234.5M | $268.1M | $304.0M | $322.7M | $12.55M | -- |
| Other Non-Current Liabilities | $556K | $0 | $0 | $29K | $143K | $0 | -- |
| **Total Non-Current Liabilities** | $246.9M | $262.5M | $304.7M | $349.6M | $374.2M | $90.56M | $11.16M |
| **Total Liabilities** | $306.6M | $329.5M | $363.1M | $404.8M | $422.9M | $109.4M | $23.81M |
| **Total Debt (incl. Leases)** | $41.27M | $37.13M | $45.07M | $51.51M | $58.33M | $82.00M | $16.63M |
| Common Stock | $6.0K | $6.0K | $4.0K | $4.0K | $4.0K | $4.0K | -- |
| Retained Earnings | -$632.5M | -$558.2M | -$471.6M | -$373.1M | -$264.3M | -$162.9M | -$94.14M |
| Accumulated Other Comp. Income | $24K | $135K | -$826K | -$3.99M | -$10K | -$7.0K | -- |
| **Total Stockholders' Equity** | -$108.5M | -$45.53M | -$77.19M | $112K | $96.87M | $146.2M | -$88.02M |
| Total Equity | -$108.5M | -$45.53M | -$77.19M | $112K | $96.87M | $146.2M | -$88.02M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $80.30M | $68.08M | $87.66M | $80.88M | $89.33M | $72.57M | $61.03M | $55.45M |
| **Cash & Short-Term Investments** | $80.30M | $68.08M | $87.66M | $80.88M | $89.33M | $72.57M | $61.03M | $55.45M |
| **Total Current Assets** | $158.3M | $170.0M | $188.1M | $163.2M | $184.1M | $203.8M | $225.4M | $249.6M |
| Property, Plant & Equipment, Net | $1.29M | $1.50M | $1.71M | $1.92M | $8.66M | $9.51M | $10.35M | $9.96M |
| Other Non-Current Assets | $21K | $3.0K | $3.0K | $4.0K | $5.0K | $6.0K | $24K | $68K |
| **Total Non-Current Assets** | $32.64M | $33.35M | $34.10M | $34.87M | $20.84M | $22.39M | $33.27M | $34.38M |
| **Total Assets** | $191.0M | $203.4M | $222.2M | $198.1M | $205.0M | $226.2M | $258.7M | $284.0M |
| Accounts Payable | $2.17M | $3.21M | $3.32M | $4.27M | $3.21M | $3.32M | $4.07M | $3.79M |
| Deferred Revenue (Current) | $18.87M | $36.59M | $52.30M | $43.19M | $65.30M | $59.72M | $51.67M | $45.61M |
| **Total Current Liabilities** | $37.31M | $50.58M | $64.40M | $59.74M | $85.09M | $77.79M | $71.31M | $66.99M |
| Deferred Revenue (Non-Current) | $127.4M | $193.2M | $193.6M | $206.0M | $193.1M | $206.8M | $222.4M | $234.5M |
| Other Non-Current Liabilities | $247K | $350K | $453K | $556K | $656K | $757K | $856K | $0 |
| **Total Non-Current Liabilities** | $167.7M | $233.9M | $234.2M | $246.9M | $209.5M | $225.1M | $249.0M | $262.5M |
| **Total Liabilities** | $205.0M | $284.4M | $298.6M | $306.6M | $294.6M | $302.9M | $320.3M | $329.5M |
| **Total Debt (incl. Leases)** | $43.87M | $43.10M | $41.99M | $41.27M | $22.53M | $23.70M | $34.85M | $37.13M |
| Common Stock | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K |
| Retained Earnings | -$601.4M | -$659.5M | -$652.3M | -$632.5M | -$610.8M | -$595.0M | -$577.0M | -$558.2M |
| Accumulated Other Comp. Income | -$123K | -$134K | -$133K | $24K | $24K | -$44K | $14K | $135K |
| **Total Stockholders' Equity** | -$14.08M | -$81.04M | -$76.41M | -$108.5M | -$89.66M | -$76.66M | -$61.65M | -$45.53M |
| Total Equity | -$14.08M | -$81.04M | -$76.41M | -$108.5M | -$89.66M | -$76.66M | -$61.65M | -$45.53M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$74.28M | -$86.62M | -$98.43M | -$108.9M | -$101.3M | -$68.80M | -$51.13M |
| Depreciation & Amortization | $3.33M | $3.12M | $3.45M | $3.32M | $3.23M | $1.33M | $693K |
| Stock-Based Compensation | $10.40M | $11.89M | $16.19M | $14.34M | $8.38M | $2.96M | $1.69M |
| Change in Payables | $481K | -$2.48M | $846K | $1.61M | $135K | $474K | $1.21M |
| **Operating Cash Flow** | -$86.10M | -$100.4M | -$118.1M | $193.6M | -$50.25M | -$31.29M | -$46.34M |
| Capital Expenditure | -$50K | -$906K | -$1.22M | -$1.21M | -$3.31M | -$16.18M | -$968K |
| **Free Cash Flow** | -$86.15M | -$101.3M | -$119.3M | $192.4M | -$53.56M | -$47.47M | -$47.30M |
| Purchases of Investments | -$131.2M | -$261.5M | -$73.90M | -$409.3M | -$99.98M | -$92.98M | -- |
| **Investing Cash Flow** | $112.0M | -$29.90M | $144.4M | -$244.3M | $36.17M | -$108.9M | -$964K |
| Common Stock Issued | -- | $103.4M | $0 | -- | -- | -- | -- |
| **Financing Cash Flow** | $1.02M | $105.4M | $1.78M | $1.76M | $22.42M | $217.5M | $23.97M |
| **Net Change in Cash** | $26.96M | -$24.88M | $28.12M | -$48.95M | $8.34M | $77.27M | -$23.33M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $58.15M | -$7.19M | -$19.88M | -$21.66M | -$15.85M | -$17.94M | -$18.83M | -$19.50M |
| Depreciation & Amortization | $200K | $200K | $238K | $802K | $900K | $900K | $827K | $761K |
| Stock-Based Compensation | $2.52M | $2.55M | $2.38M | $2.24M | $2.73M | $2.73M | $2.69M | $2.48M |
| Change in Payables | -$1.03M | -$69K | -$990K | $1.05M | -$110K | -$747K | $284K | $334K |
| **Operating Cash Flow** | -$18.24M | -$17.84M | -$25.27M | -$22.27M | -$18.86M | -$21.00M | -$23.97M | -$24.52M |
| Capital Expenditure | -$7.0K | -$50K | $0 | $0 | $0 | -$22K | -$28K | -$479K |
| **Free Cash Flow** | -$18.25M | -$17.89M | -$25.27M | -$22.27M | -$18.86M | -$21.02M | -$24.00M | -$25.00M |
| Purchases of Investments | -$13.60M | -$37.08M | -$66.94M | -$33.98M | -$4.00M | -$42.14M | -$51.12M | -$39.65M |
| **Investing Cash Flow** | $24.19M | -$2.97M | -$17.72M | $13.23M | $35.57M | $33.83M | $29.40M | $22.29M |
| Common Stock Issued | -- | $0 | $50.00M | -- | $0 | $0 | $0 | -- |
| **Financing Cash Flow** | $6.28M | -$22K | $49.77M | $581K | $49K | $254K | $139K | $4.0K |
| **Net Change in Cash** | $12.22M | -$20.83M | $6.79M | -$8.46M | $16.76M | $13.09M | $5.57M | -$2.22M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -279.5% | -454.3% | -315.9% | -609.2% | -7637.1% | -15937.4% | -- |
| **Net Profit Margin** | -240.3% | -383.2% | -288.2% | -566.3% | -7681.6% | -16000.0% | -- |
| Return on Equity (ROE) | -- | -- | -- | -97216.1% | -104.6% | -47.1% | -- |
| Return on Assets (ROA) | -37.5% | -30.5% | -34.4% | -26.9% | -19.5% | -26.9% | -228.8% |
| Current Ratio | 2.73x | 3.73x | 4.11x | 6.37x | 9.44x | 10.12x | 1.33x |
| Quick Ratio | 1.35x | 0.83x | 1.37x | 0.95x | 2.08x | 4.92x | 1.18x |
| Debt to Equity | -- | -- | -- | 459.88x | 0.60x | 0.56x | -- |
| **Revenue Growth (YoY)** | +36.8% | -33.8% | +77.6% | +1357.8% | +206.7% | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -161.0% | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -162.0% | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | +1160.8% | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | 2.1% | -198.0% | -301.3% | -279.5% | -352.9% | -380.0% | -414.4% | -454.3% |
| **Net Profit Margin** | 8.4% | -175.8% | -266.9% | -240.3% | -294.2% | -311.9% | -342.2% | -383.2% |
| Return on Assets (ROA) | 4.9% | -31.8% | -33.9% | -37.5% | -35.2% | -33.3% | -31.1% | -30.5% |
| Current Ratio | 4.24x | 3.36x | 2.92x | 2.73x | 2.16x | 2.62x | 3.16x | 3.73x |
| Quick Ratio | 2.15x | 1.35x | 1.36x | 1.35x | 1.05x | 0.93x | 0.86x | 0.83x |
| **Revenue Growth (YoY)** | +924.7% | +112.7% | -45.1% | +223.8% | +4.4% | +9.7% | +17.9% | -50.5% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
